Pharmacokinetic study results released evaluating interactions between LIVALO® and protease inhibitor combination in healthy volunteers
22 July 2012 | By Eli Lilly and Company
Results from a pharmacokinetic study...
List view / Grid view
News
Pfizer’s Crizotinib receives positive opinion for conditional marketing authorization from the CHMP
20 July 2012 | By Pfizer
“The CHMP’s positive opinion brings us a step closer..."
Novartis gains FDA approval for Afinitor® in advanced breast cancer marking a significant milestone for women battling this disease
20 July 2012 | By Novartis
The US FDA has approved Afinitor® tablets...
Sanofi and Regeneron launch comprehensive Phase 3 clinical program with LDL cholesterol-lowering PCSK9 antibody
20 July 2012 | By Sanofi
ODYSSEY will comprise over 10 clinical trials...
Catalent expert invited to speak on the advantages of single use biomanufacturing for facility expansions
19 July 2012 | By Catalent Pharma Solutions
Why single use is ideal for cell line development and bio-manufacturing...
Pfizer and Northwestern University win LYRICA® patent case
19 July 2012 | By Pfizer
“The Court’s decision recognizes the infringement & validity of our LYRICA® patents..."
FDA clears Accu-Chek Combo system – Roche’s new interactive insulin pump system for people with diabetes
19 July 2012 | By Roche
The system will be available in the United States in the second half of 2012...
European Medicines Agency accepts regulatory submission for bazedoxifene/conjugated estrogens
19 July 2012 | By Pfizer
The EMA has accepted for review the MAA for bazedoxifene/conjugated estrogens...
Freeman Technology and guests celebrate official presentation of 2012 Queen’s Award
19 July 2012 | By Kapler Communications Ltd
On 13 July, Dame Janet Trotter, presented Tim Freeman with the 2012 Queen’s Award...
BRISK-FL Study with investigational compound brivanib in hepatocellular carcinoma does not meet overall survival primary endpoint
19 July 2012 | By Bristol-Myers Squibb Company
Results of the phase III BRISK-FL clinical trial...
HIV care collaborative with Atlanta, Houston and Philadelphia health departments
19 July 2012 | By Merck
Initiative is designed to improve access to care in support of U.S. National HIV/AIDS Strategy...
Nestlé Health Science develops brain health portfolio with new investment
18 July 2012 | By Nestlé
Nestlé Health Science has acquired a stake in a US firm Accera...
Sanofi announces 2012 Patient Group Bursary winners
18 July 2012 | By Sanofi
Ataxia UK, Crohn’s & Colitis UK & Muscular Dystrophy Campaign share £50,000 to help better the lives of patients throughout the UK...
Myeloma UK announces opening of an innovative new study with a novel drug combination
18 July 2012 | By Myeloma UK
Myeloma UK announced the opening of MUK three...
Catalent expert will present at the “Drug Development Decisions: The NDA Simulation Workshop” for the PERI
18 July 2012 | By Catalent Pharma Solutions
Carolyn Finkle, VP, Global Regulatory Consulting to present...
